Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trialJosé Ramón Arribas, José M. Gatell, Pierre‐Marie Girard et al.|The Lancet Infectious Diseases|2015Cited by 143
Efficacy of Elbasvir/Grazoprevir in Early Chronic G1/G4 Hepatitis C infection in HIV/HCV co-infected patients with mild fibrosisJosep Mallolas, Laura Lorente Prieto, Elisa de Lazzari et al.|Gastroenterología y Hepatología|2020Cited by 2